Phase III doses application of Abdala candidate clinical trial ends in eastern Cuba

The study applied in three-shot doses included more than 48,000 volunteers from the capitals of Santiago de Cuba, Guantánamo and Granma provinces, in order to test its effectiveness against COVID-19.

La entrada Phase III doses application of Abdala candidate clinical trial ends in eastern Cuba se publicó primero en OnCubaNews English.